Single User License: $2,600.00
Multi User License: $3,200.00
Enterprise License: $4,900.00
L-Phenylalanine (LPA) is a crystalline form and water soluble and is an electrically neutral amino acid which is obtained from Dairy products, meal, egg and white or skimmed milk. It is used biochemically from proteins, coded by DNA. This amino acid is responsible for tyrosine, the monoamine signaling molecules dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), and the skin pigment melanin. Generally, this is used for protein foods and drinks, which is necessary for the nutrition of humans and most animals. Medically, the phenylalanine is used for depression, attention deficit-hyperactivity disorder (ADHD), Parkinson's disease, chronic pain, osteoarthritis, rheumatoid arthritis, alcohol withdrawal symptoms, and a skin disease called vitiligo.
Europe is the leading suppliers of L-Phenylalanine (LPA) products, and it will continue to the position for the forecasted period. Europeans are protein food consults; they prefer high protein food commonly in snacks, cereals, and bars category. This compound in various food and beverage products is included for its reputed analgesic and antidepressant qualities. It is also used in the manufacturing of the artificial sweetener aspartame.
European region has many opportunities to increase the L-Phenylalanine market because in this region, the food industry sector is one of the largest and most important manufacturing sectors. It is the second largest in the manufacturing industry. By effective use of economies scale, there are higher chances for leading companies to open the L-Phenylalanine market.
The report also covers the complete competitive landscape of the Europe L-Phenylalanine (LPA) market with company profiles of key players such as:
SEGMENTATIONS IN REPORT:
Main Categories